Labcorp Holdings Inc. (NYSE: LH)’s stock price has plunge by 0.56relation to previous closing price of 202.73. Nevertheless, the company has seen a 0.31% surge in its stock price over the last five trading sessions. zacks.com reported 2024-07-02 that Labcorp’s (LH) concentrated development in high-growth areas and strategic partnerships appear encouraging.
Is It Worth Investing in Labcorp Holdings Inc. (NYSE: LH) Right Now?
Labcorp Holdings Inc. (NYSE: LH) has a price-to-earnings ratio that is above its average at 41.16x. The stock has a 36-month beta value of 1.05. Opinions on the stock are mixed, with 10 analysts rating it as a “buy,” 3 as “overweight,” 6 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for LH is 83.97M, and at present, short sellers hold a 2.24% of that float. On July 04, 2024, the average trading volume of LH was 738.73K shares.
LH’s Market Performance
LH stock saw an increase of 0.31% in the past week, with a monthly gain of 4.54% and a quarterly increase of -3.95%. The volatility ratio for the week is 1.75%, and the volatility levels for the last 30 days are 1.92% for Labcorp Holdings Inc. (LH). The simple moving average for the last 20 days is 1.18% for LH stock, with a simple moving average of -3.24% for the last 200 days.
Analysts’ Opinion of LH
Many brokerage firms have already submitted their reports for LH stocks, with Argus repeating the rating for LH by listing it as a “Buy.” The predicted price for LH in the upcoming period, according to Argus is $250 based on the research report published on March 25, 2024 of the current year 2024.
Leerink Partners, on the other hand, stated in their research note that they expect to see LH reach a price target of $260. The rating they have provided for LH stocks is “Outperform” according to the report published on February 26th, 2024.
Evercore ISI gave a rating of “In-line” to LH, setting the target price at $240 in the report published on February 09th of the current year.
LH Trading at 0.80% from the 50-Day Moving Average
After a stumble in the market that brought LH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -12.91% of loss for the given period.
Volatility was left at 1.92%, however, over the last 30 days, the volatility rate increased by 1.75%, as shares surge +3.65% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +0.39% upper at present.
During the last 5 trading sessions, LH rose by +0.31%, which changed the moving average for the period of 200-days by +1.10% in comparison to the 20-day moving average, which settled at $201.85. In addition, Labcorp Holdings Inc. saw -10.31% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at LH starting from van der Vaart Sandra D, who sale 2,000 shares at the price of $210.83 back on May 14 ’24. After this action, van der Vaart Sandra D now owns 5,637 shares of Labcorp Holdings Inc., valued at $421,655 using the latest closing price.
ANDERSON KERRII B, the Director of Labcorp Holdings Inc., sale 250 shares at $200.10 during a trade that took place back on May 02 ’24, which means that ANDERSON KERRII B is holding 15,722 shares at $50,025 based on the most recent closing price.
Stock Fundamentals for LH
Current profitability levels for the company are sitting at:
- 0.09 for the present operating margin
- 0.27 for the gross margin
The net margin for Labcorp Holdings Inc. stands at 0.04. The total capital return value is set at 0.09. Equity return is now at value 4.36, with 2.17 for asset returns.
Based on Labcorp Holdings Inc. (LH), the company’s capital structure generated 0.4 points at debt to capital in total, while cash flow to debt ratio is standing at 0.22. The debt to equity ratio resting at 0.66. The interest coverage ratio of the stock is 5.5.
Currently, EBITDA for the company is 1.7 billion with net debt to EBITDA at 3.44. When we switch over and look at the enterprise to sales, we see a ratio of 1.87. The receivables turnover for the company is 5.58for trailing twelve months and the total asset turnover is 0.74. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.88.
Conclusion
To sum up, Labcorp Holdings Inc. (LH) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
